Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed May 14, 2019 · 10-Q · 44 days after period end · 0001493152-19-006965
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Net Income | -$1.41M | -$1.45M | -$2.92M | -$12.26M |
| EPS Diluted | -$0.19 | -$0.33 | -$0.08 | -$0.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed May 14, 2019 · 44 d after period end
